Resume-aware faculty matching

Find professors who actually fit you

Review faculty evidence in public, then use the workspace to turn your background into a shortlist, outreach, and meeting prep.

Profile-awarePaper evidenceSix agents
Gary  W. Falk

Gary W. Falk

University of Pennsylvania · Rehabilitation Medicine

Active 1961–2026

h-index77
Citations24.7k
Papers723215 last 5y
Funding

Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.

See your match with Gary W. Falk — sign in to PhdFit.Sign in

About

Gary W. Falk, MD, MS, is an Emeritus Professor of Medicine (Gastroenterology) at the University of Pennsylvania's Perelman School of Medicine. He is a member of the Hospital of the University of Pennsylvania Abramson Comprehensive Cancer Center Cancer Control Research Program and holds the position of University Associate Staff at Children's Hospital of Philadelphia. Dr. Falk specializes in esophageal diseases, including Barrett's esophagus, eosinophilic esophagitis, GERD diagnosis and treatment, achalasia, motility abnormalities, extraesophageal GERD, dysphagia, and esophageal cancer. His research focuses on the chemoprevention, detection, diagnosis, and epidemiology of Barrett's esophagus and eosinophilic esophagitis, as well as advanced endoscopic imaging techniques. Dr. Falk's educational background includes a B.S. in Biology-Geology from the University of Rochester, an M.D. from the University of Rochester School of Medicine and Dentistry, and an M.S. in Clinical Research from Case Western Reserve University School of Medicine Clinical Scholars Program.

Research topics

  • Medicine
  • Internal medicine
  • Pathology
  • Biology
  • Computer Science
  • Gastroenterology
  • Intensive care medicine
  • Surgery
  • Artificial Intelligence
  • Cancer research

Selected publications

  • Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline

    The American Journal of Gastroenterology · 2022-03-31 · 476 citations

    articleOpen access

    Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly lethal cancer with an increasing incidence over the last 5 decades. These revised guidelines implement Grading of Recommendations, Assessment, Development, and Evaluation methodology to propose recommendations for the definition and diagnosis of BE, screening for BE and esophageal adenocarcinoma, surveillance of patients wit…

  • Eosinophilic Esophagitis

    JAMA · 2021 · 265 citations

    Senior authorCorresponding

    Importance: Eosinophilic esophagitis (EoE) is a chronic immune-mediated inflammatory disease of the esophagus that affects an estimated 34.4/100 000 people in Europe and North America. EoE affects both children and adults, and causes dysphagia, food impaction of the esophagus, and esophageal strictures. Observations: EoE is defined by symptoms of esophageal dysfunction, such as vomiting, dysphagia, or feeding difficulties, in a patient with an esophageal biopsy demonstrating at least 15 eosinoph…

  • Anti–Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis

    New England Journal of Medicine · 2020-10-21 · 263 citations

    articleOpen access

    BACKGROUND: Eosinophilic gastritis and duodenitis are characterized by gastrointestinal mucosal eosinophilia, chronic symptoms, impaired quality of life, and a lack of adequate treatments. Mast-cell activity may contribute to the pathogenesis of the conditions. AK002 (lirentelimab) is an anti-Siglec-8 antibody that depletes eosinophils and inhibits mast cells and that has shown potential in animal models as a treatment for eosinophilic gastritis and duodenitis. METHODS: In this phase 2 trial, we…

  • International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature

    Clinical Gastroenterology and Hepatology · 2022 · 165 citations

  • Generation and Characterization of Patient‐Derived Head and Neck, Oral, and Esophageal Cancer Organoids

    Current Protocols in Stem Cell Biology · 2020 · 90 citations

    ) Support Protocol: Production of RN in HEK293T cell conditioned medium.

Frequent coauthors

  • Amitabh Chak

    249 shared
  • William M. Grady

    243 shared
  • Jacques Van Dam

    210 shared
  • John M. Inadomi

    University of Utah

    209 shared
  • Nicholas J. Shaheen

    207 shared
  • Sanford D. Markowitz

    202 shared
  • Prateek Sharma

    Vellore Institute of Technology University

    202 shared
  • Sumeet K. Mittal

    196 shared

Labs

  • Falk LabPI

Education

  • MS, Clinical Scholars

    Case Western Reserve University

    2006
  • MD, Medicine

    University of Rochester

    1980
  • BS, Biology-Geology

    University of Rochester

    1976

Similar researchers at University of Pennsylvania

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Gary W. Falk

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup